Skip to main content

Advertisement

SpringerLink
Log in

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—authors’ reply

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Raschi E, Diemberger I, Cosmi B, De Ponti F (2018) ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations. Intern Emerg Med 13(1):1–9

    Article  PubMed  Google Scholar 

  2. Campiotti L, Suter MB, Bolzacchini E, Squizzato A (2018) ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations: comment. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1838-6

    Article  PubMed  Google Scholar 

  3. Douxfils J, Haguet H, Mullier F, Chatelain C, Graux C, Dogné JM (2016) Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic review and meta-analysis. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2015.5932 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  4. Chai-Adisaksopha C, Lam W, Hillis C (2016) Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis. Leuk Lymphoma 57(6):1300–1310

    Article  PubMed  CAS  Google Scholar 

  5. Teo YL, Ho HK, Chan A (2015) Metabolism-related pharmacokinetic drug–drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations. Br J Clin Pharmacol 79(2):241–253

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Irnerio, 48, 40126, Bologna, Italy

    Emanuel Raschi & Fabrizio De Ponti

  2. Department of Specialist, Diagnostic and Experimental Medicine, Institute of Cardiology, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum - University of Bologna, Bologna, Italy

    Igor Diemberger

  3. Division of Angiology and Blood Coagulation, Department of Specialist, Diagnostic and Experimental Medicine, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum - University of Bologna, Bologna, Italy

    Benilde Cosmi

Authors
  1. Emanuel Raschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Igor Diemberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benilde Cosmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fabrizio De Ponti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emanuel Raschi.

Ethics declarations

Conflict of interest

Emanuel Raschi and Fabrizio De Ponti declare no conflicts of interest relevant to the present manuscript. Igor Diemberger reports minor speaker fees from Bayer and Boehringer Ingelheim. Benilde Cosmi reports personal fees from Daiichi Sankyo, during the conduct of the study, personal fees from Janssen, outside the submitted work.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this study, formal consent was not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raschi, E., Diemberger, I., Cosmi, B. et al. ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—authors’ reply. Intern Emerg Med 13, 635–636 (2018). https://doi.org/10.1007/s11739-018-1853-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-018-1853-7

Search

Navigation